Orsini - Rare Disease Pharmacy Solutions

Leading the Way in Cell & Gene Therapy At Orsini, we’re proud to be the leading independent specialty pharmacy dispensing cell and gene therapies (CAGT). With 6 launched therapies—and more on the horizon—we’re dedicated to ensuring patients have access to these life-changing treatments. From navigating patient access challenges and managing ultra-cold chain logistics to providing exceptional support for treatment centers, Orsini is committed to advancing innovation and outcomes for patients receiving CAGT treatment. Watch this video to learn more about how our team supports the treatment journey: https://bit.ly/3YXTHAq #CellAndGeneTherapy #CAGT #CGT #SpecialtyPharmacy #RareDisease #NoPatientLeftBehind

We are proud to share that Vertex Pharmaceuticals has chosen Orsini to dispense gene-editing therapy CASGEVY? (exagamglogene autotemcel). Read the full press release here: https://bit.ly/4hBAvkz #NoPatientLeftBehind #CRISPR #CAGT #CGT

https://lnkd.in/giWywhSX

Today, we honor and express our deepest gratitude to veterans who have served and sacrificed for our country. To all veterans, we thank you for your service. We are committed to serving you with the same dedication and respect you've shown to our country. #VeteransDay #ThankYouVeterans #OrsiniCares

“It’s been Orsini’s honor to offer care to hereditary angioedema (HAE) patients and their families for over 13 years, and our team is very familiar with the unique needs and difficulties that they face every day,” Brandon Tom, Orsini’s CEO, said. “We’re excited to partner with Cycle Pharmaceuticals to add SAJAZIR to our portfolio, further enhancing our ability to serve the HAE community.” Read the full press release here: https://bit.ly/4hzKR4r #specialtypharmacy #patientcare #NoPatientLeftBehind #HAE

We’re excited to participate in this week's Specialty Networks & Patient Support Services Summit hosted by The Healthcare Innovation Company (thINc). If you're attending, don’t miss Orsini's Nick Calla on the panel: "Managing the Rare Disease Patient Experience Amidst the Gene Therapy Revolution." #ThincSummit #SpecialtyPharmacy #RareDiseaseCare

October is National Niemann-Pick Disease Awareness Month ?? At Orsini, we're committed to supporting patients affected by Niemann-Pick disease, a rare and life-threatening genetic condition. We are proud to work closely with healthcare providers, caregivers, and pharmaceutical partners to ensure access to life-changing therapies for Niemann-Pick patients. Together, we can make a difference in the lives of those impacted by Niemann-Pick disease. Learn more about the support we provide through our Genetics Center of Excellence: https://bit.ly/3zUHELU #NiemannPickAwareness #NPCAwareness #RareDiseaseSupport #PatientCare #OrsiniCares #NoPatientLeftBehind

We are proud to share that scPharmaceuticals has chosen Orsini to distribute FUROSCIX? (furosemide injection) 80 mg/10mL for subcutaneous use. This medication is indicated for the treatment of congestion due to fluid overload in adults with chronic heart failure. Read the full press release here: https://lnkd.in/eMVFMKk5 #specialtypharmacy #patientcare #NoPatientLeftBehind

?? What is a Patient Advocate? ?? Discover the vital role that patient advocates like our own Jenny Barnes play in supporting families affected by rare diseases. Jenny guides families living with Hereditary Angioedema (HAE) through the complexities of care, helping them access the treatments they need to manage their condition effectively. Learn more about how patient advocates make a difference every day: https://bit.ly/3Y2GZ33 #HAEAwareness #HAE #OrsiniCares #MomOnAMission

We love seeing rare diseases like Duchenne muscular dystrophy getting the mainstream coverage they deserve! ?? Raising awareness is crucial for advancing research, supporting families, and connecting patients with life-changing therapies. Every story shared is a step toward better care and a brighter future for the Duchenne community: https://bit.ly/40dHeev